Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.

High hydrostatic pressure has been used to inactivate pathogens in foods for decades. There is a great potential to adapt this technology to inactivate pathogens in plasma and derivatives. To better evaluate the potential of this method, pathogen inoculated plasma samples were pressurized under diff...

Full description

Bibliographic Details
Main Authors: Chunhui Yang, Guohui Bian, Hong Yang, Xinmin Zhang, Limin Chen, Jingxing Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4999174?pdf=render
id doaj-cbb231874fd748b0a902ea98e0e61163
record_format Article
spelling doaj-cbb231874fd748b0a902ea98e0e611632020-11-25T01:30:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01118e016177510.1371/journal.pone.0161775Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.Chunhui YangGuohui BianHong YangXinmin ZhangLimin ChenJingxing WangHigh hydrostatic pressure has been used to inactivate pathogens in foods for decades. There is a great potential to adapt this technology to inactivate pathogens in plasma and derivatives. To better evaluate the potential of this method, pathogen inoculated plasma samples were pressurized under different pressure application modes and temperatures. The inactivation efficacy of pathogens and activities of plasma proteins were monitored after treatment. The CFUs of E.coli was examined as the indicator of the inactivation efficiency. The factor V and VIII were chosen as the indicator of the plasma function. Preliminary experiments identified optimized treatment conditions: 200-250MPa, with 5×1 minute multi-pulsed high pressure at near 0°C (ice-water bath). Under this conditions, the inactivation efficacy of EMCV was >8.5log. The CFUs of E. coli were reduced by 7.5log, B. cereus were 8log. However, PPV and S. aureus cannot be inactivated efficiently. The activities of factor II, VII, IX, X, XI, XII, fibrinogen, IgG, IgM stayed over 95% compared to untreated. Factor V and VIII activity was maintained at 46-63% and 77-82%, respectively.http://europepmc.org/articles/PMC4999174?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Chunhui Yang
Guohui Bian
Hong Yang
Xinmin Zhang
Limin Chen
Jingxing Wang
spellingShingle Chunhui Yang
Guohui Bian
Hong Yang
Xinmin Zhang
Limin Chen
Jingxing Wang
Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
PLoS ONE
author_facet Chunhui Yang
Guohui Bian
Hong Yang
Xinmin Zhang
Limin Chen
Jingxing Wang
author_sort Chunhui Yang
title Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
title_short Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
title_full Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
title_fullStr Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
title_full_unstemmed Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma.
title_sort development of high hydrostatic pressure applied in pathogen inactivation for plasma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description High hydrostatic pressure has been used to inactivate pathogens in foods for decades. There is a great potential to adapt this technology to inactivate pathogens in plasma and derivatives. To better evaluate the potential of this method, pathogen inoculated plasma samples were pressurized under different pressure application modes and temperatures. The inactivation efficacy of pathogens and activities of plasma proteins were monitored after treatment. The CFUs of E.coli was examined as the indicator of the inactivation efficiency. The factor V and VIII were chosen as the indicator of the plasma function. Preliminary experiments identified optimized treatment conditions: 200-250MPa, with 5×1 minute multi-pulsed high pressure at near 0°C (ice-water bath). Under this conditions, the inactivation efficacy of EMCV was >8.5log. The CFUs of E. coli were reduced by 7.5log, B. cereus were 8log. However, PPV and S. aureus cannot be inactivated efficiently. The activities of factor II, VII, IX, X, XI, XII, fibrinogen, IgG, IgM stayed over 95% compared to untreated. Factor V and VIII activity was maintained at 46-63% and 77-82%, respectively.
url http://europepmc.org/articles/PMC4999174?pdf=render
work_keys_str_mv AT chunhuiyang developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
AT guohuibian developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
AT hongyang developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
AT xinminzhang developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
AT liminchen developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
AT jingxingwang developmentofhighhydrostaticpressureappliedinpathogeninactivationforplasma
_version_ 1725088546649276416